After OpenAI hearing, A.I. experts urge Congress to listen to more diverse voices on regulation
OpenAI CEO Sam Altman testifies before a Senate Judiciary Privacy, Technology, and the Law Subcommittee hearing titled ‘Oversight of A.I.: Rules for Artificial Intelligence’ on Capitol Hill in Washington, U.S., May 16, 2023. REUTERS/Elizabeth Frantz
Elizabeth Frantz | Reuters
At most tech CEO hearings in recent years, lawmakers have taken a contentious tone, grilling executives over their data-privacy practices, competitive methods and more.
But at Tuesday’s hearing on AI oversight including OpenAI CEO Sam Altman, lawmakers seemed notably more welcoming toward the ChatGPT maker. One senator even went as far as asking whether Altman would be qualified to administer rules regulating the industry.
Altman’s warm welcome on Capitol Hill, which included a dinner discussion the night prior with dozens of House lawmakers and a separate speaking event Tuesday afternoon attended by House Speaker Kevin McCarthy, R-Calif., has raised concerns from some AI experts who were not in attendance this week.
These experts caution that lawmakers’ decision to learn about the technology from a leading industry executive could unduly sway the solutions they seek to regulate AI. In conversations with CNBC in the days after Altman’s testimony, AI leaders urged Congress to engage with a diverse set of voices in the field to ensure a wide range of concerns are addressed, rather than focus on those that serve corporate interests.
OpenAI did not immediately respond to a request for comment on this story.
A friendly tone
For some experts, the tone of the hearing and Altman’s other engagements on the Hill raised alarm.
Lawmakers’ praise for Altman at times sounded almost like “celebrity worship,” according to Meredith Whittaker, president of the Signal Foundation and co-founder of the AI Now Institute at New York University.
“You don’t ask the hard questions to people you’re engaged in a fandom about,” she said.
“It doesn’t sound like the kind of hearing that’s oriented around accountability,” said Sarah Myers West, managing director of the AI Now Institute. “Saying, ‘Oh, you should be in charge of a new regulatory agency’ is not an accountability posture.”
West said the “laudatory” tone of some representatives following the dinner with Altman was surprising. She acknowledged it may “signal that they’re just trying to sort of wrap their heads around what this new market even is.”
But she added, “It’s not new. It’s been around for a long time.”
Safiya Umoja Noble, a professor at UCLA and author of “Algorithms of Oppression: How Search Engines Reinforce Racism,” said lawmakers who attended the dinner with Altman seemed “deeply influenced to appreciate his product and what his company is doing. And that also doesn’t seem like a fair deliberation over the facts of what these technologies are.”
“Honestly, it’s disheartening to see Congress let these CEOs pave the way for carte blanche, whatever they want, the terms that are most favorable to them,” Noble said.
Real differences from the social media era?
At Tuesday’s Senate hearing, lawmakers made comparisons to the social media era, noting their surprise that industry executives showed up asking for regulation. But experts who spoke with CNBC said industry calls for regulation are nothing new and often serve an industry’s own interests.
“It’s really important to pay attention to specifics here and not let the supposed novelty of someone in tech saying the word ‘regulation’ without scoffing distract us from the very real stakes and what’s actually being proposed, the substance of those regulations,” said Whittaker.
“Facebook has been using that strategy for years,” Meredith Broussard, New York University professor and author of “More Than a Glitch: Confronting Race, Gender, and Ability Bias in Tech,” said of the call for regulation. “Really, what they do is they say, ‘Oh, yeah, we’re definitely ready to be regulated.’… And then they lobby [for] exactly the opposite. They take advantage of the confusion.”
Experts cautioned that the kinds of regulation Altman suggested, like an agency to oversee AI, could actually stall regulation and entrench incumbents.
“That seems like a great way to completely slow down any progress on regulation,” said Margaret Mitchell, researcher and chief ethics scientist at AI company Hugging Face. “Government is already not resourced enough to well support the agencies and entities they already have.”
Ravit Dotan, who leads an AI ethics lab at the University of Pittsburgh as well as AI ethics at generative AI startup Bria.ai, said that while it makes sense for lawmakers to take Big Tech companies’ opinions into account since they are key stakeholders, they shouldn’t dominate the conversation.
“One of the concerns that is coming from smaller companies generally is whether regulation would be something that is so cumbersome that only the big companies are really able to deal with [it], and then smaller companies end up having a lot of burdens,” Dotan said.
Several researchers said the government should focus on enforcing the laws already on the books and applauded a recent joint agency statement that asserted the U.S. already has the power to enforce against discriminatory outcomes from the use of AI.
Dotan said there were bright spots in the hearing when she felt lawmakers were “informed” in their questions. But in other cases, she said she wished lawmakers had pressed Altman for deeper explanations or commitments.
For example, when asked about the likelihood that AI will displace jobs, Altman said that eventually it will create more quality jobs. While Dotan said she agreed with that assessment, she wished lawmakers had asked Altman for more potential solutions to help displaced workers find a living or gain skills training in the meantime, before new job opportunities become more widely available.
“There are so many things that a company with the power of OpenAI backed by Microsoft has when it comes to displacement,” Dotan said. “So to me, to leave it as, ‘Your market is going to sort itself out eventually,’ was very disappointing.”
Diversity of voices
A key message AI experts have for lawmakers and government officials is to include a wider array of voices, both in personal background and field of experience, when considering regulating the technology.
“I think that community organizations and researchers should be at the table; people who have been studying the harmful effects of a variety of different kinds of technologies should be at the table,” said Noble. “We should have policies and resources available for people who’ve been damaged and harmed by these technologies … There are a lot of great ideas for repair that come from people who’ve been harmed. And we really have yet to see meaningful engagement in those ways.”
Mitchell said she hopes Congress engages more specifically with people involved in auditing AI tools and experts in surveillance capitalism and human-computer interactions, among others. West suggested that people with expertise in fields that will be affected by AI should also be included, like labor and climate experts.
Whittaker pointed out that there may already be “more hopeful seeds of meaningful regulation outside of the federal government,” pointing to the Writers Guild of America strike as an example, in which demands include job protections from AI.
Government should also pay greater attention and offer more resources to researchers in fields like social sciences, who have played a large role in uncovering the ways technology can result in discrimination and bias, according to Noble.
“Many of the challenges around the impact of AI in society has come from humanists and social scientists,” she said. “And yet we see that the funding that is predicated upon our findings, quite frankly, is now being distributed back to computer science departments that work alongside industry.”
Noble said she was “stunned” to see that the White House’s announcement of funding for seven new AI research centers seemed to have an emphasis on computer science.
“Most of the women that I know who have been the leading voices around the harms of AI for the last 20 years are not invited to the White House, are not funded by [the National Science Foundation and] are not included in any kind of transformative support,” Noble said. “And yet our work does have and has had tremendous impact on shifting the conversations about the impact of these technologies on society.”
Noble pointed to the White House meeting earlier this month that included Altman and other tech CEOs, such as Google’s Sundar Pichai and Microsoft’s Satya Nadella. Noble said the photo of that meeting “really told the story of who has put themselves in charge. …The same people who’ve been the makers of the problems are now somehow in charge of the solutions.”
Bringing in independent researchers to engage with government would give those experts opportunities to make “important counterpoints” to corporate testimony, Noble said.
Still, other experts noted that they and their peers have engaged with government about AI, albeit without the same media attention Altman’s hearing received and perhaps without a large event like the dinner Altman attended with a wide turnout of lawmakers.
Mitchell worries lawmakers are now “primed” from their discussions with industry leaders.
“They made the decision to start these discussions, to ground these discussions in corporate interests,” Mitchell said. “They could have gone in a totally opposite direction and asked them last.”
Mitchell said she appreciated Altman’s comments on Section 230, the law that helps shield online platforms from being held responsible for their users’ speech. Altman conceded that outputs of generative AI tools would not necessarily be covered by the legal liability shield and a different framework is needed to assess liability for AI products.
“I think, ultimately, the U.S. government will go in a direction that favors large tech corporations,” Mitchell said. “My hope is that other people, or people like me, can at least minimize the damage, or show some of the devil in the details to lead away from some of the more problematic ideas.”
“There’s a whole chorus of people who have been warning about the problems, including bias along the lines of race and gender and disability, inside AI systems,” said Broussard. “And if the critical voices get elevated as much as the commercial voices, then I think we’re going to have a more robust dialogue.”
WATCH: Can China’s ChatGPT clones give it an edge over the U.S. in an A.I. arms race?
A logo hangs on the building of the Beijing branch of Semiconductor Manufacturing International Corporation (SMIC) on December 4, 2020 in Beijing, China.
Vcg | Visual China Group | Getty Images
Shares of Semiconductor Manufacturing International Corporation, China’s largest contract chip maker, fell nearly 7% Friday after its first-quarter earnings missed estimates.
After trading on Thursday, the company reported a first-quarter revenue of $2.24 billion, up about 28% from a year earlier. Meanwhile, profit attributable to shareholders surged 162% year on year to $188 million.
However, both figures missed LSEG mean estimates of $2.34 billion in revenue and $225.1 million in net income, as well as the company’s own forecasts.
During an earnings call Friday, an SMIC representative said the earnings missed original guidance due to “production fluctuations” which sent blended average selling prices falling. This impact is expected to extend into the second quarter, they added.
For the current quarter, the chipmaker forecasted revenue to fall 4% to 6% sequentially. Gross margin is also expected to fall within the range of 18% to 20%, compared to 22.5% in the first quarter.
Still, the first quarter saw SMIC’s wafer shipments increase by 15% from the previous quarter and by about 28% year-on-year.
In the earnings call, SMIC attributed that growth to customer shipment pull in, brought by changes in geopolitics and increased demand driven by government policies such as domestic trade-in programs and consumption subsidies.
In another positive sign for the company, its first-quarter capacity utilization— the percentage of total available manufacturing capacity that is being used at any given time— reached 89.6%, up 4.1% quarter on quarter.
“SMIC’s nearly 90% utilization rate reflects strong domestic demand for semiconductors, likely driven by smartphone and consumer electronics production,” said Ray Wang, a Washington-based semiconductor and technology analyst, adding that the demand was also reflected in the company’s strong quarterly revenue growth.
Meanwhile, the company said in the earnings call that it is “currently in an important period of capacity construction, roll out, and continuously increasing market share.”
However, SMIC’s first-quarter research and development spending decreased to $148.9 million, down from $217 million in the previous quarter.
Amid increased demand, it will be crucial for SMIC to continue ramping up their capacity, Simon Chen, principal analyst of semiconductor manufacturing at Informa Tech told CNBC.
SMIC generates most of its revenue from older-generation semiconductors, often referred to as “mature-node” or “legacy” chips, which are commonly found in consumer electronics and industrial equipment.
The state-backed chipmaker is critical to Beijing’s ambitions to build a self-sufficient semiconductor supply chain, with the government pumping billions into such efforts. Over 84% of its first-quarter revenue was derived from customers in China.
“The localization transformation of the supply chain has been strengthened, and more manufacturing demand has shifted back domestically,” a representative said Friday.
However, chip analysts say the chipmaker’s ability to increase capacity in advance chips — used in applications that demand higher levels of computing performance and efficiency at higher yields — is limited.
This is due to U.S.-led export controls, which prevent it from accessing some of the world’s most advanced chip-making equipment from the Netherlands-based ASML.
Nevertheless, the chipmaker appears to be making some breakthroughs. Advanced chips manufactured by SMIC have reportedly appeared in various Huawei products, notably in the Mate 60 Pro smartphone and some AI processors.
In the earnings call, the company also said it would closely monitor the potential impacts of the U.S.-China trade war on its demand, noting a lack of visibility for the second half of the year.
Phelix Lee, an equity analyst for Morningstar focused on semiconductors, told CNBC that the impacts of U.S. tariffs on SMIC are limited due to most of its revenue coming from Chinese customers.
While U.S. customers make up about 8-15% of revenue on a quarterly basis, the chips usually remain and are consumed in Chinese products and end users, he said.
“There could be some disruption to chemical, gas, and equipment supply; but the firm is working on alternatives in China and other non-U.S. regions,” he added.
SMIC’s Hong Kong-listed shares have gained over 32.23% year-to-date.
Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.
Smith Collection | Gado | Getty Images
Amazon is expanding its online pharmacy to fill prescription pet medications, the company announced Thursday.
The company said it has added “hundreds of commonly prescribed pet medications” to its U.S. site, ranging from flea and tick solutions to treatments for chronic conditions.
Prescriptions are purchased via Amazon’s storefront and must be approved by a veterinarian. Online pet pharmacy Vetsource will oversee the dispensing and delivery of medications, said Amazon, adding that items are typically delivered within two to six days.
Amazon launched its digital drugstore in 2020 with the added perk of discounts and free delivery for Prime members. The company has been working to speed up prescription shipments over the past year, bringing same-day delivery to a handful of U.S. cities. Last October, Amazon set a goal to make speedy medicine delivery available in nearly half of the U.S. in 2025.
The new pet medication offerings puts Amazon into more direct competition with online pet pharmacy Chewy, as well as Walmart, which offers pet prescription delivery.
Amazon Pharmacy is part of the company’s growing stable of healthcare offerings, which also includes One Medical, the primary care provider it acquired for roughly $3.9 billion in July 2022. Amazon’s online pharmacy was born out of the company’s 2018 acquisition of online pharmacy PillPack.
-
Sports3 years ago‘Storybook stuff’: Inside the night Bryce Harper sent the Phillies to the World Series
-
Sports1 year agoStory injured on diving stop, exits Red Sox game
-
Sports2 years agoGame 1 of WS least-watched in recorded history
-
Sports2 years agoMLB Rank 2023: Ranking baseball’s top 100 players
-
Sports4 years ago
Team Europe easily wins 4th straight Laver Cup
-
Environment2 years agoJapan and South Korea have a lot at stake in a free and open South China Sea
-
Environment2 years agoGame-changing Lectric XPedition launched as affordable electric cargo bike
-
Business3 years agoBank of England’s extraordinary response to government policy is almost unthinkable | Ed Conway